- Home
- BTTR vs SNPX Comparison
BTTR vs SNPX Comparison
Compare BTTR & SNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTTR
- SNPX
- Stock Information
- Founded
- BTTR 1986
- SNPX 2012
- Country
- BTTR United States
- SNPX United States
- Employees
- BTTR N/A
- SNPX N/A
- Industry
- BTTR Beverages (Production/Distribution)
- SNPX Medicinal Chemicals and Botanical Products
- Sector
- BTTR Consumer Staples
- SNPX Health Care
- Exchange
- BTTR Nasdaq
- SNPX Nasdaq
- Market Cap
- BTTR 3.4M
- SNPX 3.1M
- IPO Year
- BTTR N/A
- SNPX N/A
- Fundamental
- Price
- BTTR $2.00
- SNPX $2.30
- Analyst Decision
- BTTR Strong Buy
- SNPX Strong Buy
- Analyst Count
- BTTR 1
- SNPX 1
- Target Price
- BTTR $10.00
- SNPX $14.00
- AVG Volume (30 Days)
- BTTR 105.1K
- SNPX 11.5K
- Earning Date
- BTTR 05-16-2025
- SNPX 05-14-2025
- Dividend Yield
- BTTR N/A
- SNPX N/A
- EPS Growth
- BTTR N/A
- SNPX N/A
- EPS
- BTTR N/A
- SNPX N/A
- Revenue
- BTTR $34,975,000.00
- SNPX N/A
- Revenue This Year
- BTTR $629.09
- SNPX N/A
- Revenue Next Year
- BTTR N/A
- SNPX N/A
- P/E Ratio
- BTTR N/A
- SNPX N/A
- Revenue Growth
- BTTR N/A
- SNPX N/A
- 52 Week Low
- BTTR $1.45
- SNPX $1.84
- 52 Week High
- BTTR $7.41
- SNPX $5.38
- Technical
- Relative Strength Index (RSI)
- BTTR 50.69
- SNPX 48.08
- Support Level
- BTTR $1.73
- SNPX $2.05
- Resistance Level
- BTTR $2.16
- SNPX $2.21
- Average True Range (ATR)
- BTTR 0.19
- SNPX 0.18
- MACD
- BTTR 0.03
- SNPX 0.03
- Stochastic Oscillator
- BTTR 53.28
- SNPX 75.31
About BTTR Better Choice Company Inc.
Better Choice Co Inc is a pet health and wellness portfolio company, offering consumers a wide variety of recognized premium pet products and hemp-derived CBD supplements. Its portfolio includes kibble and canned dog and cat food, freeze-dried raw dog food and treats, vegan dog food and treats, oral care products, supplements and grooming aids. Its core products sold under the Halo brand are sustainably sourced, derived from real whole meat and no rendered meat meal and include non-GMO fruits and vegetables. Its core products sold under the TruDog brand are made according to nutritional philosophy of fresh, meat-based nutrition and minimal processing.
About SNPX Synaptogenix Inc.
Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.